GPS Wealth Strategies Group LLC Lowers Stake in Chemed Corporation $CHE

Posted by Geri Gentry on May 23rd, 2026

GPS Wealth Strategies Group LLC reduced its holdings in shares of Chemed Corporation (NYSE:CHE – Free Report) by 69.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 616 shares of the company’s stock after selling 1,401 shares during the period. GPS Wealth Strategies Group LLC’s holdings in Chemed were worth $264,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Smartleaf Asset Management LLC grew its position in Chemed by 71.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after purchasing an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. purchased a new position in Chemed during the 4th quarter worth $27,000. Global Retirement Partners LLC grew its position in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares during the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new position in Chemed during the 3rd quarter worth $45,000. Finally, Danske Bank A S grew its position in Chemed by 250.0% during the 4th quarter. Danske Bank A S now owns 140 shares of the company’s stock worth $60,000 after purchasing an additional 100 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Down 0.4%

Shares of NYSE:CHE opened at $439.70 on Friday. The company has a market cap of $5.83 billion, a price-to-earnings ratio of 23.96, a PEG ratio of 1.66 and a beta of 0.54. The firm’s 50-day simple moving average is $400.27 and its 200-day simple moving average is $425.05. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $581.20.

Chemed (NYSE:CHE – Get Free Report) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts predict that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be issued a $0.60 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is presently 13.08%.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.33% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Oppenheimer lowered their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Royal Bank Of Canada raised their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Finally, Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Saturday. Two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $501.50.

Read Our Latest Research Report on CHE

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.